|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 32783 |
FusionGeneSummary for SCARB1_EEA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SCARB1_EEA1 | Fusion gene ID: 32783 | Hgene | Tgene | Gene symbol | SCARB1 | EEA1 | Gene ID | 949 | 8411 |
| Gene name | scavenger receptor class B member 1 | early endosome antigen 1 | |
| Synonyms | CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1 | MST105|MSTP105|ZFYVE2 | |
| Cytomap | 12q24.31 | 12q22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | scavenger receptor class B member 1CD36 and LIMPII analogous 1CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1scavenger receptor class B type III | early endosome antigen 1early endosome antigen 1, 162kDearly endosome-associated proteinendosome-associated protein p162zinc finger FYVE domain-containing protein 2 | |
| Modification date | 20180520 | 20180522 | |
| UniProtAcc | Q8WTV0 | Q15075 | |
| Ensembl transtripts involved in fusion gene | ENST00000339570, ENST00000415380, ENST00000261693, ENST00000376788, ENST00000546215, ENST00000535005, ENST00000541205, ENST00000540495, ENST00000544327, | ENST00000322349, ENST00000547833, | |
| Fusion gene scores | * DoF score | 7 X 5 X 6=210 | 22 X 3 X 11=726 |
| # samples | 7 | 20 | |
| ** MAII score | log2(7/210*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(20/726*10)=-1.85996954822103 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SCARB1 [Title/Abstract] AND EEA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SCARB1 | GO:0010886 | positive regulation of cholesterol storage | 9211901 |
| Hgene | SCARB1 | GO:0015920 | lipopolysaccharide transport | 12651854 |
| Hgene | SCARB1 | GO:0032497 | detection of lipopolysaccharide | 12651854 |
| Hgene | SCARB1 | GO:0034384 | high-density lipoprotein particle clearance | 9211901 |
| Hgene | SCARB1 | GO:0043654 | recognition of apoptotic cell | 9211901 |
| Hgene | SCARB1 | GO:0051000 | positive regulation of nitric-oxide synthase activity | 11792700 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | ACC | TCGA-OR-A5JP-01A | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000339570 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000339570 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000415380 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000415380 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000261693 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000261693 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| 5CDS-intron | ENST00000376788 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| 5CDS-intron | ENST00000376788 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000546215 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000546215 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000535005 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000535005 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000541205 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000541205 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000540495 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000540495 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000544327 | ENST00000322349 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
| intron-intron | ENST00000544327 | ENST00000547833 | SCARB1 | chr12 | 125262186 | - | EEA1 | chr12 | 93229203 | - |
Top |
FusionProtFeatures for SCARB1_EEA1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SCARB1 | EEA1 |
| Receptor for different ligands such as phospholipids,cholesterol ester, lipoproteins, phosphatidylserine and apoptoticcells (PubMed:12016218, PubMed:12519372, PubMed:21226579).Receptor for HDL, mediating selective uptake of cholesteryl etherand HDL-dependent cholesterol efflux (PubMed:26965621). Alsofacilitates the flux of free and esterified cholesterol betweenthe cell surface and apoB-containing lipoproteins and modifiedlipoproteins, although less efficiently than HDL. May be involvedin the phagocytosis of apoptotic cells, via its phosphatidylserinebinding activity (PubMed:12016218). {ECO:0000269|PubMed:12016218,ECO:0000269|PubMed:12519372, ECO:0000269|PubMed:16020694,ECO:0000269|PubMed:21226579, ECO:0000269|PubMed:26965621}. (Microbial infection) Acts as a receptor for hepatitis Cvirus in hepatocytes and appears to facilitate its cell entry(PubMed:12356718, PubMed:12913001, PubMed:18000990). Bindingbetween SCARB1 and the hepatitis C virus glycoprotein E2 isindependent of the genotype of the viral isolate(PubMed:12356718). Mediates uptake of M.fortuitum, E.coli andS.aureus (PubMed:16020694). {ECO:0000269|PubMed:12356718,ECO:0000269|PubMed:16020694, ECO:0000269|PubMed:18000990}. | Binds phospholipid vesicles containingphosphatidylinositol 3-phosphate and participates in endosomaltrafficking. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SCARB1_EEA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SCARB1_EEA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SCARB1 | PDZK1, APOA1, APOA2, CUL1, CAND1, FBXO6, KRTAP5-9, KRTAP10-9, HLA-DRA, HLA-DPA1, ATP1B3, HLA-C, BTNL8, PTPRK, NAAA, PON2, TMEM17, TMEM216, CDH1, TMEM30B, CLDN7, SFTPC, DEFA1, SCGB1D4, BTNL3, NCEH1, TMPRSS11B, TRIM25 | EEA1 | RAB22A, RAB5A, EEA1, STX12, NSF, RABEP1, RAB5C, IGF1R, PXK, PDCD6IP, RABGEF1, TNK2, VCP, ERBB2, CFTR, CCDC8, RNF2, BMI1, FCGR2A, PPP1R3C, MARS, PCNA, TP53, RRAD, NUPL1, MLLT6, SERPINB2, FUOM, BMP1, SNRNP27, TMA16, USP47, RAB31, PTPRQ, PIBF1, SNX27 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SCARB1_EEA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SCARB1_EEA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | SCARB1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | SCARB1 | C0016427 | Follicular cyst | 1 | CTD_human |
| Hgene | SCARB1 | C0019196 | Hepatitis C | 1 | CTD_human |
| Hgene | SCARB1 | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
| Hgene | SCARB1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Hgene | SCARB1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Hgene | SCARB1 | C0024809 | Marijuana Abuse | 1 | CTD_human |
| Hgene | SCARB1 | C0031391 | Phencyclidine Abuse | 1 | CTD_human |
| Hgene | SCARB1 | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
| Hgene | SCARB1 | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|